(TGTX) - Earnings & Price History

TGTX: - 7.825, $515.62M, -0.33 (-3.99%)

Sector: Healthcare - Industry: Biotechnology

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. It develops TG-1101 (ublituximab), a novel glycol engineered monoclonal antibody that targets a epitope on the CD20 antigen found on the surface of B-lymphocytes developed to aid in the depletion of circulating B-cells; and TG-1101 in combination with TGR-1202 for relapsed/refractory non-Hodgkins lymphoma and chronic lymphocytic leukemia. The company also develops TGR-1202, an orally available phosphoinositide-3-kinase delta inhibitor with nanomolar potency to the delta isoform and high selectivity over the alpha, beta, and gamma isoforms, as well as for hematologic malignancies. In addition, it develops a pre-clinical program to develop the inhibitors of interleukin-1 recepto

Past TGTX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-10BMO-0.3611.411.811.911.212.60.85%-4.20%-3.39%6.67M
2017-03-09AMC-0.3611.411.811.911.212.60.85%-4.20%-3.39%6.67M
2017-03-08AMC-0.3611.810.1510.6510.25124.93%10.80%16.26%11.40M
2017-03-07AMC-0.3610.1510.910.99.8511.19-6.88%-6.88%3.04M
2017-03-06AMC-0.3510.910.210.59.8511.62.94%3.81%6.86%3.44M
2016-11-07AMC-0.315.35.15.24.955.351.96%1.92%3.92%328.32K
2016-08-08AMC-0.295.565.555.55.495.6-0.90%▲1.09%0.18%533.30K
2016-05-10AMC-0.367.917.847.997.88.991.91%-1.00%0.89%549.76K
2016-05-05AMC-0.367.988.148.057.838.43-1.11%-0.87%-1.97%258.13K
2016-05-04AMC-0.368.148.578.698.138.691.40%-6.33%-5.02%345.38K
2016-05-03AMC-0.368.578.878.758.48.9-1.35%-2.06%-3.38%262.37K
2016-05-02AMC-0.368.879.289.128.779.43-1.72%-2.74%-4.42%244.65K
2016-03-07AMC-0.328.610.139.328.549.95-8.00%-7.73%-15.10%647.98K
2015-11-09-0.3413.813.6213.6613.1713.930.29%1.02%1.32%435.23K
2015-08-10-0.316.1116.061615.9916.53-0.37%▲0.69%0.31%464.50K
2014-11-11BMOTg Therapeutics-0.35-0.5112.9112.5512.512.0713.42-0.40%3.28%2.87%685.50K
2014-08-07Tg Therapeutics-0.28-0.367.467.837.867.28.190.38%▲-5.09%-4.73%336.50K
2014-05-13BMOTg Therapeutics-0.214.744.814.754.735.32-1.25%-0.21%-1.46%366.20K
2014-03-06BMOTg Therapeutics-0.19-0.186.836.926.926.767.29-1.30%-1.30%273.10K
2013-11-14Tg Therapeutics-0.25-0.163.353.453.43.253.51-1.45%-1.47%-2.90%218.40K
2013-08-02BMOTg Therapeutics-0.18-0.296.076.236.246.036.30.16%▲-2.72%-2.57%125.50K
2013-06-19Tg Therapeutics-0.14-0.177.497.217.177.75-1.53%5.49%3.88%305.00K
2012-11-09BMOTg Therapeutics-0.12-0.162.22.252.32.12.32.22%-4.35%-2.22%18.20K

Login | Register
Saturday Aug 18, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades